相关实验视频
Updated: May 23, 2025

08:42
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
4.3K
糖分酶PKM2通过调节STAT3酸化来调节炎症性骨质结晶发生
Mingjuan Li1, Feng Li1, Chongjie Zhu1
1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, China.
The Journal of biological chemistry
|March 8, 2025
概括
酸激酶M2 (PKM2) 通过增强糖解和STAT3信号传递,驱动牙周炎的炎症性骨质细胞形成. 使用TEPP-46准PKM2可减少骨质损失,为牙周炎提供潜在的治疗方法.
科学领域:
- 生物化学 生化学
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
- 牙周病学 牙周病学
背景情况:
- 牙周炎是一种慢性炎症性疾病,通过骨质细胞引起大气泡骨损失.
- 酸盐激酶M2 (PKM2) 参与了超出新陈代谢的细胞过程,但其在骨质细胞形成中的作用尚不清楚.
- 了解PKM2的功能对于开发新的牙周炎疗法至关重要.
研究的目的:
- 为了研究PKM2在炎症性骨质细胞形成中的作用.
- 探索PKM2作为牙周炎的潜在治疗点.
主要方法:
- 在体外研究中,使用了用脂多糖 (LPS) 刺激的小鼠骨髓衍生的巨细胞 (BMM).
- 分析了PKM2表达,糖解活性和骨质细胞形成标志物 (TRAP,RT-qPCR,西部斑点).
- 使用葡萄糖分解抑制剂 (2-DG) 和PKM2激活剂 (TEPP-46) 在实验室和体内牙周炎的小鼠模型.
主要成果:
- LPS刺激增加了骨质细胞形成,糖溶解和骨质细胞中PKM2的表达.
- 用2-DG抑制骨质细胞形成和相关基因表达的抑制糖解.
- 在体内,TEPP-46治疗降低了核PKM2,降低了p-STAT3,抑制了骨质细胞形成,并改善了膜骨损失.
结论:
- 通过调节糖解和STAT3信号传递,PKM2调节炎症性骨质细胞生成.
- PKM2与p-STAT3的相互作用对骨质细胞分化至关重要.
- 针对PKM2,特别是其核转移和STAT3酸化,是牙周炎的有前途的治疗策略.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Role of Matrix Metalloproteases in Degradation of ECM
2.3K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.3K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K

